Cited by 420Rheumatoid Arthritis Research and TherapiesAtherosclerosis and Cardiovascular DiseasesCardiovascular Health and Risk Factors

Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions

Open access
Mason, J. C., Libby, P.·2015·European Heart Journal

Abstract

A variety of systemic inflammatory rheumatic diseases associate with an increased risk of atherosclerotic events and premature cardiovascular (CV) disease. Although this recognition has stimulated intense basic science and clinical research, the precise nature of the relationship between local and systemic inflammation, their interactions with traditional CV risk factors, and their role in accelerating atherogenesis remains unresolved. The individual rheumatic diseases have both shared and unique attributes that might impact CV events. Understanding of the positive and negative influences of individual anti-inflammatory therapies remains rudimentary. Clinicians need to adopt an evidence-based approach to develop diagnostic techniques to identify those rheumatologic patients most at risk of CV disease and to develop effective treatment protocols. Development of optimal preventative and disease-modifying approaches for atherosclerosis in these patients will require close collaboration between basic scientists, CV specialists, and rheumatologists. This interface presents a complex, important, and exciting challenge.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu403

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chronic inflammation triggers endothelial dysfunction and initiates premature atherosclerosis.

    “Chronic inflammation triggers endothelial dysfunction and initiates premature atherosclerosis.”

    From Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study (2021) · cites this paper as [9]

    The Rheumatoid arthritis section (page unavailable) reports endothelial dysfunction in patients with RA and says vascular impairments may predispose to atherosclerosis. The Conclusion’s Figure 1 caption says systemic inflammatory rheumatic disorders predispose to premature, accelerated atherosclerosis. The claim overstates these qualified findings as a definite causal sequence in which chronic inflammation triggers endothelial dysfunction and initiates atherosclerosis. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythemato- sus. Arthritis Rheum 2001;44:2331 -2337.
  2. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737 -2745.

Cited by

Sorted by citations

Authors
Mason, J. C., & Libby, P.
Affiliations
  • Hammersmith Hospital (GB)
  • Brigham and Women's Hospital (US)
Venue
European Heart Journal
Published
2014-11-27
Volume
36
Issue
8
Pages
482-489
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2072453475
Cited by
420
References
130
Citations by year
2026: 13 · 2025: 27 · 2024: 53 · 2023: 38 · 2022: 50 · 2021: 29 · 2020: 42 · 2019: 44 · 2018: 40 · 2017: 31 · 2016: 28 · 2015: 22 · 2014: 2 · 2012: 1
FWCI
4.54
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • National Institute for Health and Care Research
  • British Heart Foundation
  • Imperial College London
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL080472, R01HL080472)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
cardiovascular disease, chronic inflammation, atherosclerosis, atherogenesis, cardiovascular risk factors, anti-inflammatory therapy, cardiovascular risk prediction, cardiovascular disease prevention
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Rheumatoid, Biological Factors, Coronary Artery Disease, Gout, Humans, Immunosuppressive Agents, Lupus Erythematosus, Systemic, Rheumatic Diseases, Risk Factors, Vasculitis, Biomarkers, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review